Number needed to treat for net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation

Rungroj Krittayaphong; Satchana Pumprueg; Ahthit Yindeengam; Professor Gregory Lip

doi:10.1002/joa3.70023

Back

Number needed to treat for net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation

Article 2025 en

Abstract

1 min read

Warfarin had a negative NNTnet compared to no OAC. Only warfarin with TTR 65% has positive NNTnet. NOACs had positive NNTnet compared to no OAC and when compared to warfarin.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Oral anticoagulants in extremely high risk very elderly (&gt;90 years) patients with Atrial Fibrillation

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Article2020

Comparison between non-vitamin K antagonist oral anticoagulants versus warfarin for the risk of dementia in Asian patients with non-valvular atrial fibrillation

S.R Lee, E K Choi, Sunyoung Park, Kyungdo Han, Seil Oh, Professor Gregory Lip

Article2019

P4793Comparing the effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in the elderly Asian patients with atrial fibrillation

Tze‐Fan Chao, Jo‐Nan Liao, Professor Gregory Lip, S A Chen

Article2022

Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis

Stephanie L. Harrison, Benjamin J. R. Buckley, Leona A. Ritchie, Riccardo Proietti, Paula Underhill, Deirdre A. Lane, Professor Gregory Lip

Article2019

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage

Peter Brønnum Nielsen, Flemming Skjøth, Mette Søgaard, Jette Nordstrøm Kjældgaard, Professor Gregory Lip, Torben Bjerregaard Larsen

Number needed to treat for net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation

Abstract

Discussion(0)

Related publications

Oral anticoagulants in extremely high risk very elderly (&amp;gt;90 years) patients with Atrial Fibrillation

Comparison between non-vitamin K antagonist oral anticoagulants versus warfarin for the risk of dementia in Asian patients with non-valvular atrial fibrillation

P4793Comparing the effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in the elderly Asian patients with atrial fibrillation

Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage

Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation